Cargando…

Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury

This study investigated the improvement and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury (STBI). A retrospective analysis was performed on 86 patients with intracranial infections after cranial...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiang, Chen, Hongxing, Zhu, Chao, Chen, Fangzhou, Sun, Suohui, Liang, Nan, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489086/
https://www.ncbi.nlm.nih.gov/pubmed/31086592
http://dx.doi.org/10.3892/etm.2019.7503
_version_ 1783414754353610752
author Zhang, Qiang
Chen, Hongxing
Zhu, Chao
Chen, Fangzhou
Sun, Suohui
Liang, Nan
Zheng, Wei
author_facet Zhang, Qiang
Chen, Hongxing
Zhu, Chao
Chen, Fangzhou
Sun, Suohui
Liang, Nan
Zheng, Wei
author_sort Zhang, Qiang
collection PubMed
description This study investigated the improvement and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury (STBI). A retrospective analysis was performed on 86 patients with intracranial infections after cranial trauma operation in Tai'an Traditional Chinese Medicine Hospital and Affiliated Hospital of Taishan Medical University from May 2004 to June 2017. The patients were divided into the control group (43 patients) and the experimental group (43 patients) according to the treatment. Patients in the control group were intravenously infused with vancomycin hydrochloride (1.0 g, Q12H) and meropenem (2.0 g, Q8H). After lumbar cistern drainage was performed for the release of cerebrospinal fluid (CSF), patients in the experimental group were slowly given vancomycin 20 mg. After the tube was flushed with 2 ml of 0.9% sodium chloride injection, the patients were slowly given meropenem 20 mg, bid. The clinical efficacy, cure time and treatment cost of patients in the two groups were observed. The adverse reactions and sequelae after 6 months of treatment were recorded. The response rate (RR) of patients in the experimental group was significantly higher than that in the control group (P<0.05). The cure time of patients in the experimental group was significantly lower than that in the control group (P<0.05). The treatment cost of patients in the experimental group was significantly lower than that in the control group (P<0.05). The incidence of adverse reactions of patients, incidence of sequelae of patients in the experimental group was significantly lower than that in the control group (P<0.05). Intrathecal meropenem and vancomycin is more effective than intravenous administration in the treatment of intracranial infection after craniotomy. It can significantly shorten the treatment time and reduce the treatment cost, with better safety.
format Online
Article
Text
id pubmed-6489086
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-64890862019-05-13 Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury Zhang, Qiang Chen, Hongxing Zhu, Chao Chen, Fangzhou Sun, Suohui Liang, Nan Zheng, Wei Exp Ther Med Articles This study investigated the improvement and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury (STBI). A retrospective analysis was performed on 86 patients with intracranial infections after cranial trauma operation in Tai'an Traditional Chinese Medicine Hospital and Affiliated Hospital of Taishan Medical University from May 2004 to June 2017. The patients were divided into the control group (43 patients) and the experimental group (43 patients) according to the treatment. Patients in the control group were intravenously infused with vancomycin hydrochloride (1.0 g, Q12H) and meropenem (2.0 g, Q8H). After lumbar cistern drainage was performed for the release of cerebrospinal fluid (CSF), patients in the experimental group were slowly given vancomycin 20 mg. After the tube was flushed with 2 ml of 0.9% sodium chloride injection, the patients were slowly given meropenem 20 mg, bid. The clinical efficacy, cure time and treatment cost of patients in the two groups were observed. The adverse reactions and sequelae after 6 months of treatment were recorded. The response rate (RR) of patients in the experimental group was significantly higher than that in the control group (P<0.05). The cure time of patients in the experimental group was significantly lower than that in the control group (P<0.05). The treatment cost of patients in the experimental group was significantly lower than that in the control group (P<0.05). The incidence of adverse reactions of patients, incidence of sequelae of patients in the experimental group was significantly lower than that in the control group (P<0.05). Intrathecal meropenem and vancomycin is more effective than intravenous administration in the treatment of intracranial infection after craniotomy. It can significantly shorten the treatment time and reduce the treatment cost, with better safety. D.A. Spandidos 2019-06 2019-04-18 /pmc/articles/PMC6489086/ /pubmed/31086592 http://dx.doi.org/10.3892/etm.2019.7503 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhang, Qiang
Chen, Hongxing
Zhu, Chao
Chen, Fangzhou
Sun, Suohui
Liang, Nan
Zheng, Wei
Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
title Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
title_full Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
title_fullStr Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
title_full_unstemmed Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
title_short Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
title_sort efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489086/
https://www.ncbi.nlm.nih.gov/pubmed/31086592
http://dx.doi.org/10.3892/etm.2019.7503
work_keys_str_mv AT zhangqiang efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury
AT chenhongxing efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury
AT zhuchao efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury
AT chenfangzhou efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury
AT sunsuohui efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury
AT liangnan efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury
AT zhengwei efficacyandsafetyofintrathecalmeropenemandvancomycininthetreatmentofpostoperativeintracranialinfectioninpatientswithseveretraumaticbraininjury